Biotech News

Genefitletics has entered into a strategic partnership with Genique Lifesciences to provide Genomics & bioinformatics based preventive healthcare solution.

April 6, 2021

The next generation immune checkpoint inhibitors and stimulators market : Roots Analysis

Roots Analysis has done a detailed study on Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

April 6, 2021

The peptides and macrocycle drug discovery services market : Roots Analysis

Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.

April 6, 2021

The prefilled syringes market is projected to grow at an annualized rate of ~5%: Roots Analysis

Roots Analysis has done a detailed study on Prefilled Syringes, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

April 6, 2021

The prefilled syringes market is estimated to be worth over USD 2.5 billion : Roots Analysis

Despite having been available for more than two decades, the demand for prefilled syringes continues to grow, given the numerous benefits they offer over conventional injectable drug delivery systems

April 6, 2021

Over 60 companies across the globe claim to manufacture drug products / drug substances - "Roots Analysis"

The COVID-19 pandemic has severely impaired the overall pharmaceutical supply chain, mostly owing to the absence of workers at manufacturing sites and restrictions imposed on distribution networks.

April 5, 2021

The continuous manufacturing market is projected to grow at an annualized rate of over 15%- "Roots Analysis"

Roots Analysis has done a detailed study on Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030.”, covering key aspects of the industry and identifying future growth opportunities.

April 5, 2021

The continuous manufacturing market is estimated to be worth around USD 2 billion - "Roots Analysis"

Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing

April 5, 2021

The global digital therapeutics market ,growing at a CAGR of 19.7%- "Roots Analysis"

Roots Analysis has done a detailed study on Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030 (Based on Type of Solution

April 5, 2021

digital therapeutics market is projected to be worth over USD 8.8 billion by 2030- "Roots Analysis"

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.

April 5, 2021

The global digital therapeutics market is projected to be worth over USD 8.86 billion- "Roots Analysis"

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions

April 5, 2021

subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion- Roots Analysis

Roots Analysis has done a detailed report on Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 covering key aspects of the industry and identifying future growth opportunities

April 1, 2021

The subcutaneous biologic drugs and affiliated technologies market - Roots Analysis

Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals

April 1, 2021

Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%- Roots Analysis

Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market, 2020-2030 covering key aspects of the industry and identifying future growth opportunities

March 31, 2021

The Companion Diagnostics Development Services Market - Roots analysis

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise

March 31, 2021

Injectors market is projected to grow at an annualized rate of ~35%- Roots Analysis

Roots Analysis has done a detailed study on Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices.

March 31, 2021

wearable injectors market is estimated to be worth around USD 600 million- "Roots Analysis"

Large Volume Wearable Injectors have made it convenient to self-administer drugs in the home care setting, providing substantial cost benefits.

March 31, 2021

biomanufacturing market is estimated to be worth USD 9.3 billion in 2030- "Roots Analysis"

Benefits offered by microbial biomanufacturing, such as low production costs and faster development timelines, have led many innovators to adopt these platforms for next generation biologics, offering lucrative opportunities for CMOs / CDMOs

March 30, 2021

The microbial contract biomanufacturing market is projected to be worth USD 9.3 billion - "Roots Analysis"

The growing pipeline of biologics that can be produced in microbial systems, such as antibody fragments and plasmid-based therapies, is anticipated to offer lucrative opportunities to service providers serving this niche, but growing market segment

March 30, 2021

stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030 - "Roots Analysis"

Roots Analysis has done a detailed study on “Global Stem Cells Market: Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic, Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal, Progenitor)

March 30, 2021

280 therapies under evaluation, the stem cell therapy market - "Roots Analysis"

With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism.

March 30, 2021

80 companies currently claim to offer manufacturing related services

Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations.

March 25, 2021

The oligonucleotide synthesis, modification and purification

Roots Analysis has done a detailed study on “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications

March 25, 2021

The oligonucleotide synthesis, modification and purification services market - Roots Analysis

The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs

March 25, 2021

The oligonucleotide synthesis, modification and purification services market

The rapidly growing demand for oligonucleotides, coupled to complex manufacturing procedures and high capital investments required for setting up manufacturing facilities, has generated a range of new opportunities for custom manufacturers

March 25, 2021

The ‘Patient Recruitment and Retention Services, 2019-2030’ - Roots Analysis

The ‘Patient Recruitment and Retention Services, 2019-2030’ report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services.

March 25, 2021

close to 140 companies claim to be actively engaged in offering patient recruitment / retention services to the pharmaceutical

A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers

March 25, 2021

News by Category: Biotech